세계의 제약용 임상시험 공급 및 물류 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Clinical Trial Supply and Logistic for Pharmaceutical was estimated to be worth US$ 2360 million in 2024 and is forecast to a readjusted size of US$ 4066 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Clinical Trial Supply and Logistic for Pharmaceutical refers to a specialized service system providing comprehensive drug and material supply, storage, distribution, and temperature-controlled transportation throughout the entire clinical trial lifecycle for pharmaceutical companies, contract research organizations (CROs), and research institutions. This service encompasses post-manufacturing clinical packaging, labeling, kit assembly, batch traceability, global supply chain design, customs clearance, GMP/GDP-compliant warehousing, and precise distribution. With increasing trial complexity and the growth of multi-center, cross-regional clinical studies, clinical trial supply and logistics have become essential in mitigating R&D risks, improving trial efficiency, and safeguarding patient safety. Through digitalized supply chain management, intelligent temperature-control solutions, and globally compliant networks, the sector offers end-to-end, fully traceable services that accelerate the path from drug development to commercialization.

The pharmaceutical clinical trial supply and logistics sector is experiencing unprecedented growth driven by shorter drug development cycles and the expansion of global clinical trial networks. The rapid advancement of precision medicine, cell and gene therapies, RNA-based drugs, and rare disease treatments is raising the bar for supply chain flexibility, traceability, and regulatory compliance. Investment in digitalized supply chain solutions, automated warehousing, and intelligent transport equipment not only enhances operational efficiency for pharmaceutical companies but also strengthens global market access. Government incentives for drug innovation and accelerated approval pathways are fostering standardized, cross-border collaboration within the industry.

Key challenges include regulatory compliance costs, the complexity of international logistics, and resource allocation pressures. Strict GMP/GDP standards and cold-chain transportation requirements worldwide necessitate continuous investments in technology and skilled personnel. Cross-border trials further complicate supply chain coordination, while geopolitical uncertainties, public health crises, and logistics capacity fluctuations heighten operational risks. Additionally, increasing demand for small-batch, multi-lot, rapid-response supply models for innovative therapies has driven up costs and supply chain agility requirements.

As the global pipeline of innovative drugs expands, the demand for clinical trial supply and logistics is shifting from basic storage and transport services to comprehensive end-to-end solutions. Pharmaceutical companies, CROs, and biotech firms increasingly prioritize compliance transparency and real-time supply chain visibility to shorten development timelines and optimize resource use. Precision medicine is driving demand for biological sample logistics, companion diagnostics, and direct-to-patient (DTP) delivery, pushing the industry toward more data-driven, personalized, and customized services. The sector is set to deeply integrate with digital clinical trial platforms and decentralized trial models, becoming a strategic asset in drug R&D.

The upstream supply chain comprises cold-chain technology, specialized packaging materials, transport containers, and digital management systems. Leading suppliers of cold-chain solutions and intelligent packaging continuously innovate to ensure drug stability during storage and transportation. High-performance insulation materials, smart temperature sensors, and single-use packaging have become standard in the industry. At the same time, the integration of advanced supply chain management platforms, automated warehousing systems, and tracking technologies strengthens lifecycle supply chain capabilities, ensuring secure and efficient operations for global clinical trial programs.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply and Logistic for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supply and Logistic for Pharmaceutical by region & country, by Type, and by Application.

The Clinical Trial Supply and Logistic for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply and Logistic for Pharmaceutical.

Market Segmentation

By Company

• Thermo Fisher Scientific
• Catalent Pharma Solutions
• Almac Group
• Parexel International
• UDG Healthcare
• PCI Services
• Marken
• Klifo A/S.
• Walden Group
• Bilcare Limited
• Biocair

Segment by Type

• Logistics & Distribution
• Manufacturing and Packaging
• Supply Chain Management
• Other

Segment by Application

• Phase I
• Phase II
• Phase III

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supply and Logistic for Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Clinical Trial Supply and Logistic for Pharmaceutical Product Introduction
• 1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Market Size Forecast (2020-2031)
• 1.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Trends & Drivers
  • 1.3.1 Clinical Trial Supply and Logistic for Pharmaceutical Industry Trends
  • 1.3.2 Clinical Trial Supply and Logistic for Pharmaceutical Market Drivers & Opportunity
  • 1.3.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Challenges
  • 1.3.4 Clinical Trial Supply and Logistic for Pharmaceutical Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Players Revenue Ranking (2024)
• 2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue by Company (2020-2025)
• 2.3 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supply and Logistic for Pharmaceutical
• 2.6 Clinical Trial Supply and Logistic for Pharmaceutical Market Competitive Analysis
  • 2.6.1 Clinical Trial Supply and Logistic for Pharmaceutical Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supply and Logistic for Pharmaceutical Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supply and Logistic for Pharmaceutical as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Logistics & Distribution
  • 3.1.2 Manufacturing and Packaging
  • 3.1.3 Supply Chain Management
  • 3.1.4 Other
• 3.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type
  • 3.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (2020-2031)
  • 3.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Phase I
  • 4.1.2 Phase II
  • 4.1.3 Phase III
• 4.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application
  • 4.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (2020-2031)
  • 4.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region
  • 5.1.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025)
  • 5.1.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031)
  • 5.1.4 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 5.2.2 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 5.3.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 5.5.2 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.3.2 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.4.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.5.2 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.6.2 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.7.2 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.9.2 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Profile
  • 7.1.2 Thermo Fisher Scientific Main Business
  • 7.1.3 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.1.4 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Thermo Fisher Scientific Recent Developments
• 7.2 Catalent Pharma Solutions
  • 7.2.1 Catalent Pharma Solutions Profile
  • 7.2.2 Catalent Pharma Solutions Main Business
  • 7.2.3 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.2.4 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Catalent Pharma Solutions Recent Developments
• 7.3 Almac Group
  • 7.3.1 Almac Group Profile
  • 7.3.2 Almac Group Main Business
  • 7.3.3 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.3.4 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Almac Group Recent Developments
• 7.4 Parexel International
  • 7.4.1 Parexel International Profile
  • 7.4.2 Parexel International Main Business
  • 7.4.3 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.4.4 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Parexel International Recent Developments
• 7.5 UDG Healthcare
  • 7.5.1 UDG Healthcare Profile
  • 7.5.2 UDG Healthcare Main Business
  • 7.5.3 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.5.4 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.5.5 UDG Healthcare Recent Developments
• 7.6 PCI Services
  • 7.6.1 PCI Services Profile
  • 7.6.2 PCI Services Main Business
  • 7.6.3 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.6.4 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.6.5 PCI Services Recent Developments
• 7.7 Marken
  • 7.7.1 Marken Profile
  • 7.7.2 Marken Main Business
  • 7.7.3 Marken Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.7.4 Marken Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Marken Recent Developments
• 7.8 Klifo A/S.
  • 7.8.1 Klifo A/S. Profile
  • 7.8.2 Klifo A/S. Main Business
  • 7.8.3 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.8.4 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Klifo A/S. Recent Developments
• 7.9 Walden Group
  • 7.9.1 Walden Group Profile
  • 7.9.2 Walden Group Main Business
  • 7.9.3 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.9.4 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Walden Group Recent Developments
• 7.10 Bilcare Limited
  • 7.10.1 Bilcare Limited Profile
  • 7.10.2 Bilcare Limited Main Business
  • 7.10.3 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.10.4 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Bilcare Limited Recent Developments
• 7.11 Biocair
  • 7.11.1 Biocair Profile
  • 7.11.2 Biocair Main Business
  • 7.11.3 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • 7.11.4 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

• 8.1 Clinical Trial Supply and Logistic for Pharmaceutical Industrial Chain
• 8.2 Clinical Trial Supply and Logistic for Pharmaceutical Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Clinical Trial Supply and Logistic for Pharmaceutical Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Clinical Trial Supply and Logistic for Pharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer